Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allan E. Surgenor
Observed names:
A. Surgenor,
A.E. Surgenor,
Allan E Surgenor,
Allan Surgenor
Institution:
Vernalis (R&D) Limited (United Kingdom)
Observed institutions:
Institute of Cancer Research,
Cancer Research UK,
Roche (United Kingdom),
Vernalis (R&D) Limited (United Kingdom)
ORCID:
0000-0002-9869-1430
Observed ORCID:
0000-0002-9869-1430
OpenAlex ID:
A5029966483
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
2016
·
András Kotschy
, Zoltán Szlavik
, et al.
·
Nature
·
1,087
4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer
2007
·
Paul A. Brough
, Wynne Aherne
, et al.
·
Journal of Medicinal Chemistry
·
455
Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening
2006
·
Nicolas Foloppe
, Lisa M. Fisher
, et al.
·
Bioorganic & Medicinal Chemistry
·
366
Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms
2004
·
Lisa Wright
, Xavier Barril
, et al.
·
Chemistry & Biology
·
271
PDF
Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design
2005
·
Brian W. Dymock
, Xavier Barril
, et al.
·
Journal of Medicinal Chemistry
·
232
Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design
2009
·
Douglas S. Williamson
, Jenifer Borgognoni
, et al.
·
Journal of Medicinal Chemistry
·
231
Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone
2009
·
Paul A. Brough
, Xavier Barril
, et al.
·
Journal of Medicinal Chemistry
·
178
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues
2007
·
Swee Y. Sharp
, Chrisostomos Prodromou
, et al.
·
Molecular Cancer Therapeutics
·
148
Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity
2011
·
Alba T. Macias
, Douglas S. Williamson
, et al.
·
Journal of Medicinal Chemistry
·
121
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor
2020
·
Zoltan Szlavik
, Marton Csekei
, et al.
·
Journal of Medicinal Chemistry
·
120
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
2010
·
Andrew Potter
, Victoria Oldfield
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
101
Structure-Based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein−Ligand Affinity
2005
·
Nicolas Foloppe
, Lisa M. Fisher
, et al.
·
Journal of Medicinal Chemistry
·
96
Structure-guided design of α-amino acid-derived Pin1 inhibitors
2009
·
Andrew J. Potter
, Stuart Ray
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
95
A fluorescence polarization assay for inhibitors of Hsp90
2006
·
R. Howes
, X. Barril
, et al.
·
Analytical Biochemistry
·
86
4-Amino derivatives of the Hsp90 inhibitor CCT018159
2006
·
Xavier Barril
, Mandy C. Beswick
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
81
3-(5-chloro-2,4-dihydroxyphenyl)-Pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone
2005
·
Paul A. Brough
, Xavier Barril
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
81
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity
2019
·
Zoltan Szlávik
, Levente Ondi
, et al.
·
Journal of Medicinal Chemistry
·
79
Structure-based discovery of a new class of Hsp90 inhibitors
2005
·
Xavier Barril
, Paul Brough
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
78
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR
2005
·
Christine M. Richardson
, Douglas S. Williamson
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
76
Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2
2005
·
Douglas S. Williamson
, Martin J. Parratt
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
74
Adenine derived inhibitors of the molecular chaperone HSP90—SAR explained through multiple X-ray structures
2003
·
Brian Dymock
, Xavier Barril
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
66
Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization
2012
·
Nicholas G.M. Davies
, Helen Browne
, et al.
·
Bioorganic & Medicinal Chemistry
·
50
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)
2017
·
Douglas S. Williamson
, Garrick P. Smith
, et al.
·
Journal of Medicinal Chemistry
·
49
PDF
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
2021
·
David Lee Walmsley
, James B. Murray
, et al.
·
Journal of Medicinal Chemistry
·
48
Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping
2007
·
Christine M. Richardson
, Claire L. Nunns
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
45
Show more works
View as search
Works count:
135
Citation count:
4,516
H-index:
29
I10-index:
31
Year
Topic
Type